Department of Pathology
Johns Hopkins Medicine
The mission of the Department of Pathology is to discover, disseminate and apply knowledge in the study of disease, to advance the field of human health, and to provide the highest quality of patient care.
![Johns Hopkins Dome](https://pathology.jhu.edu/build/assets/general/_image350500/Johns-Hopkins-Dome-1.jpg)
Department of Pathology
Johns Hopkins Medicine
The mission of the Department of Pathology is to discover, disseminate and apply knowledge in the study of disease, to advance the field of human health, and to provide the highest quality of patient care.
Department of Pathology
Johns Hopkins Medicine
The mission of the Department of Pathology is to discover, disseminate and apply knowledge in the study of disease, to advance the field of human health, and to provide the highest quality of patient care.
![Patient and Nurse](https://pathology.jhu.edu/build/assets/general/_image365/patient-nurse.jpg)
For Patients
Do you need a second opinion on your pathology diagnosis? Our expert pathologists can help assure you have the most accurate diagnosis.
Second Opinions![Charles Eberhart, M.D., Ph.D.](https://pathology.jhu.edu/build/assets/department/_image365/Charles-Eberhart.jpg)
For Clinicians
The Johns Hopkins Medical Laboratory provides world-recognized expertise in Surgical Pathology and Cytopathology consultation.
Consultation ServicesLatest News
JHU’s Translational ImmunoEngineering Hub Gets $6.4M Renewal From NIH - Sep 25, 2024
Congratulations, Natasha Bachmeyer! - Sep 21, 2024
Congratulations, Dr. Mahalia Robinson! - Aug 2, 2024
Read AllRecent Publications
Our department's impact on pathology research is evident: Johns Hopkins Pathology has been the #1 NIH-funded pathology department for 15 of the past 17 years. Below are recent highlighted publications from our department.
3D Genomic Mapping Offers New Insight into Pancreatic Precancers
Braxton AM, Kiemen AL, ... Fishman EK, Roberts NJ, Thompson ED, Cornish TC, Jiao Y, Karchin R, Hruban RH, Wu PH, Wirtz D, Wood LD. 3D genomic mapping reveals multifocality of human pancreatic precancers. Nature. 2024 May 1. Epub ahead of print.
Read full article
3D Genomic Mapping Offers New Insight into Pancreatic Precancers
![Laura Wood, M.D., Ph.D.](https://pathology.jhu.edu/build/assets/our-team/_thmbImg/Laura-Wood.jpg)
Braxton AM, Kiemen AL, ... Fishman EK, Roberts NJ, Thompson ED, Cornish TC, Jiao Y, Karchin R, Hruban RH, Wu PH, Wirtz D, Wood LD. 3D genomic mapping reveals multifocality of human pancreatic precancers. Nature. 2024 May 1. Epub ahead of print.
Gene Variants Enhance Diagnostic Accuracy of Pancreatic Cancer Tumor Markers
Ando Y, Dbouk M, Yoshida T, Saba H, Abou Diwan E, Yoshida K, Dbouk A, Blackford AL, Lin MT, Lennon AM, Burkhart RA, He J, Sokoll L, Eshleman JR, Canto MI, Goggins M.
Read full article
Gene Variants Enhance Diagnostic Accuracy of Pancreatic Cancer Tumor Markers
![Michael Goggins, M.B.B.Ch., M.D.](https://pathology.jhu.edu/build/assets/our-team/_thmbImg/Michael-Goggins.jpg)
Ando Y, Dbouk M, Yoshida T, Saba H, Abou Diwan E, Yoshida K, Dbouk A, Blackford AL, Lin MT, Lennon AM, Burkhart RA, He J, Sokoll L, Eshleman JR, Canto MI, Goggins M.
Clues for Immunotherapy Options in Intimal Sarcoma
Birkness-Gartman JE, Thomas DL 2nd, Engle LL, Voltaggio L, Thompson ED. Immune microenvironment of intimal sarcomas: Adaptive immune resistance with potential therapeutic implications. Am J Clin Pathol. 2024 Mar;161(3):256-63.
Read full article
Clues for Immunotherapy Options in Intimal Sarcoma
![Elizabeth Thompson, M.D., Ph.D.](https://pathology.jhu.edu/build/assets/our-team/_thmbImg/Elizabeth-Thompson.jpg)
Birkness-Gartman JE, Thomas DL 2nd, Engle LL, Voltaggio L, Thompson ED. Immune microenvironment of intimal sarcomas: Adaptive immune resistance with potential therapeutic implications. Am J Clin Pathol. 2024 Mar;161(3):256-63.
In the Spotlight: Novel Cytokine Signature Discovered in Bladder Cancer
VandenBussche CJ, Heaney CD, Kates M, Hooks JJ, Baloga K, Sokoll L, Rosenthal D, Detrick B. Urinary IL-6 and IL-8 as predictive markers in bladder urothelial carcinoma: A pilot study. Cancer Cytopathol. 2024 Jan;132(1):50-9.
Read full article
In the Spotlight: Novel Cytokine Signature Discovered in Bladder Cancer
![Christopher VandenBussche, M.D., Ph.D.](https://pathology.jhu.edu/build/assets/our-team/_thmbImg/Christopher-VandenBussche.jpg)
VandenBussche CJ, Heaney CD, Kates M, Hooks JJ, Baloga K, Sokoll L, Rosenthal D, Detrick B. Urinary IL-6 and IL-8 as predictive markers in bladder urothelial carcinoma: A pilot study. Cancer Cytopathol. 2024 Jan;132(1):50-9.
Grand Rounds
Each Monday at 8:30 am, the Department of Pathology hosts a series of speakers to discuss advancements in the field of disease diagnosis and treatment.
Next Session
Topic: Insights to Biology of TDP-43 Reveal a Gene Therapy for Neurodegenerative Disease -
View session details